Quick Answer
Ensysce Biosciences, Inc. reported Total Revenue of $5.07 million for fiscal year 2025.
Ensysce Biosciences, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $5.07M | -2.8% |
| 2024 | $5.21M | +133.6% |
| 2023 | $2.23M | -11.6% |
| 2022 | $2.52M | -28.5% |
| 2021 | $3.53M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $493.1K | -85.6% | -64.0% |
| June 30, 2025 | $1.37M | +654.4% | +3.9% |
| March 31, 2025 | $1.32M | +331.7% | -61.4% |
| September 30, 2024 | $3.42M | +685.3% | +1780.6% |
| June 30, 2024 | $181.8K | -62.9% | -40.5% |
| March 31, 2024 | $305.7K | -61.3% | -29.8% |
| September 30, 2023 | $435.4K | +55.9% | -11.2% |
| June 30, 2023 | $490.5K | +136.4% | -37.9% |
- Ensysce Biosciences, Inc. showed a decrease of -2.8% in Total Revenue compared to the prior fiscal year.
- Over the 2021–2025 period, Ensysce Biosciences, Inc.’s total revenue has grown by 43.5% (from $3.53 million to $5.07 million).
- The most recent figure is from Ensysce Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: